Cellular and molecular pathogenesis of periventricular white matter injury

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 3, Issue 1, 1997, Pages 96-107

  Back, Stephen A ^a,b   Volpe, Joseph J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

antioxidant enzymes; apoptosis; cytokine; development; glutamate; glutathione; growth factor; iron; oligodendrocyte; oxygen free radicals; periventricular leukomalacia

Indexed keywords

APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; DISEASE ASSOCIATION; ENCEPHALOMALACIA; HUMAN; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; WHITE MATTER;

EID: 0030892921     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1997)3:1<96::AID-MRDD12>3.0.CO;2-M     Document Type: Article

References (163)

1. Aloisi F, Agresti C, D'Urso D et al. (1988): Differentiation of bipotential glial precursors into oligodendrocytes is promoted by interaction with type-1 astrocytes in cerebellar cultures. Proc Natl Acad Sci USA 85:6167-6171.
2. Amstad P, Peskin A, Shah G et al. (1991): The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30:9305-9313.
3. Ando M, Takashima S, Mito T (1988): Endotoxin, cerebral blood flow, amino acids and brain damage in young rabbits. Brain Dev 10:365-370.
4. Armstrong R, Friedrich Jr VL, Holmes KV et al. (1990a): In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol 111:1183-1195.
5. Armstrong RC, Harvath L, Dubois-Dalcq ME (1990b): Type 1 astrocytes and oligodendrocyte-rype 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27:400-407.
6. Armstrong RC, Dorn HJ, Kufta CV et al. (1992): Pre-oligodendrocytes from adult human CNS J Neurosci 12:1538-1547.
7. Back SA, Yonezawa M, Gan X, Rosenberg PA, Volpe JJ (1995): Oligodendrocyte death induced by cystine deprivation occurs by apoptosis. Soc Neurosci Abstr 21:41.
8. Back SA, Volpe JJ, Kinney HH (1996): Immunocytochemical characterization of oligodendrocyte development in human cerebral white matter. Soc Neurosci Abstr 20:1722.
9. Balla G, Jacob HS, Balla J et al. (1992): Ferritin: A cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148-18153.
10. Banker B, Larroche J (1962): Periventricular leukomalacia of infancy: A form of neonatal anoxic encephalopathy. Arch Neurol 7:386-410.
11. Bansal R, Pfeiffer SE (1994). Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitechtural maturation, but not developmental lineage progression. Dev Biol 162: 511-524.
12. Bansal R, Warrington A, Gard A et al. (1989): Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
13. Barbarese E, Pfeiffer SE (1981): Developmental regulation of myelin basic protein in dispersed cultures. Proc Natl Acad Sci USA 74:3360-3364.
14. Baron-Van Evercooren A, Ohchon-Berthe C, Kowalski A et al. (1991): Expression of IGF-1 and insulin receptor genes in the rat central nervous system: A developmental, regional and cellular analysis. J Neurosci Res 28:244-253.
15. Barres BA, Schmid R, Sendnter M, et al. (1993): Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295
16. Barres BA, Raff MC (1994): Control of oligodendrocyte number in the developing rat optic nerve Neuron 12:935-942.
17. Barres BA, Hart IK, Coles HSR et al. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
18. Barres BA, Raff MC, Gaese F et al. (1994): A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367:371-375.
19. Bartlett WP, Li X-S, Williams M (1992): Expression of IGF-1 mRNA in the murine subventricular zone during postnatal development. Mol Brain Res 12:285-291.
20. Beck KD, Powell-Braxton L, Widmer HR et al. (1995): Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730.
21. Bodhireddy SR, Lyman WD, Rashbaum WK et al. (1994): Immunohistochemical detection of myelin basic protein is a sensitive marker of myelination in second semester human fetal spinal cord. J Neuropathol Exp Neurol 53:144-149.
22. Bogler O, Wren D, Barnett SC, Land H, Noble M (1990): Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte(O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368-6372.
23. Brody BA, Kinney HC, Kloman AS et al. (1987): Sequence of central nervous system mylelination in human infancy: I. An autopsy study of myelination. J Neuropathol Exp Neurol 46:283-301.
24. Burne JF, Staple JK, Raff MC (1996): Ghal cells are increased proportionally in transgenic nerves with increased numbers of axons. J Neurosci 16:2064-2073.
25. Butt AM, Colquhoun K (1996) Glial cells in transected optic nerves of immature rars: I. An analysis of individual cells by intracellular dye-injection. J Neurocytol 25:365-380.
26. Carson MJ, Behnnger RR, Brinster RL et al. (1993): Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10:729-740.
27. Chan PH (1992): Oxygen radicals in focal cerebral ischemia. Brain Pathol 4:59-65.
28. Choi DW, Rothman SN (1990): The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann Rev Neurosci 12:171-182.
29. Claris O, Besnier S, Lapillonne A et al. (1996): Incidence of ischemic-hemorrhagic cerebral lesions in premature infants of gestational age ≤28 weeks: A prospective ultrasound study. Biol Neonate 70:29-34.
30. Clawson CC, Hartman JF, Vernier RL (1966): Electron microscopy of the effect of gram negative endotoxin on the blood brain barrier. J Comp Neurol 127:183-198.
31. Collarim EJ, Pringle N, Mudhar H, Stevens G, Kuhn R, Monuki E, Lemke G, Richardson W (1991). Growth factors and transcription factors in oligodendrocyte development. J Cell Sci (Suppl 15):117-123.
32. Connor JR, Fine RE (1987): Development of transferrin-positive oligodendrocytes in the rat central nervous system. J Neurosci Res 17:51-59.
33. Connor JR, Menzies SL (1990): Altered distribution of iron in the central nervous system of myelin deficient rats Neuroscience 34:265-271.
34. Connor JR, Benkovic SA (1992): Iron regulation in the brain: Histochemical, biochemical, and molecular considerations. Ann Neurol 32 (Suppl):51-61.
35. Connor JR, Menzies SL (1996): Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93.
36. Connor JR, Phillips TM, Lakshman MR et al. (1987): Regional variations in the levels of transferrin in the CNS of normal and myelin-deficient rats. J Neurochem 49:1523-1529.
37. Connor JR, Menzies SL, St. Martin SM et al. (1990): Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27:595-611.
38. Connor JR, Pavlick G, Karli D et al. (1995). A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355:111-123.
39. Crickton RR, Charloteaux-Wauters M (1987): Iron transport and storage. Eur J Biochem 164:485-506.
40. Dambska M, Laure-Kamionowska M, Schmidt-Sidor B (1989): Early and late pathological changes in perinatal white matter damage. J Child Neurol 4:291-298.
41. Del Maestro R, McDonald W (1987): Distribution of superoxide dismutase, glutathione peroxidase and catalase in developing rat brain. Mech Ageing Dev 41:29-38.
42. De Vnes LS, Wigglesworth JS, Regev R et al. (1988): Evolution of penventricular leukomalacia during the neonatal period and infancy: Correlation of imaging and postmortem findings. Early Hum Dev 17:205-219.
43. Ditelberg JS, Sheldon RA, Epstein CJ et al. (1996): Brain injury after perinatal hypoxia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 39:204-208.
44. D'Souza, Alinauskas K, McCrea E, Goodyer C et al. (1995): Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15:7293-7300.
45. 3LacCer) and to its 9-O-acetylated derivative. J Biol Chem 265: 2797-2803.
46. Dubois-Dalcq M, Behar T et al. (1986): Emergence of three myelin proteins in oligodendrocyte cultures without neurons. J Cell Biol 102:384-392.
47. Dwork AJ, Schon EA, Herbert J (1988): Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 27:333-345.
48. Eitan S, Schwartz M (1993): A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 261:106-108.
49. Eizenberg O, Faber-Elman A, Gotdieb E et al. (1995): Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 14:1136-1144.
50. Ellison JA, de Vellis J (1994): Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage. J Neurosci Res 37:116-128.
51. Ellison JA, Scully SA, de Vellis J (1996): Evidence for neuronal regulation of oligodendrocyte development: Cellular localization of platelet-derived growth factor a receptor and A-chain mRNA during cerebral cortex development in the rat. J Neurosci Res 45:28-39.
52. Espinosa de los Monteros A, Zhang MS et al. (1993): O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci USA 90:50-54.
53. Fong Y, Lowry SF (1990): Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunpathol 55:157-170.
54. Fredman P, Magnant JL, Nirenberg M et al. (1984): Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. Arch Biochem Biophys 33:661-666.
55. Friede RL (1989): Developmental Neuropathology. Berlin: Springer-Verlag, pp 7-8.
56. Gallo V, Russell JT (1995): Excitatory amino acid receptors in glia: Different subtypes for distinct function? J Neurosci Res 42:1-8.
57. + channel block. J Neurosci 16:2659-2670.
58. Gard AL, Pfeiffer SE (1989): Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: Myelinogenic potential in a defined environment. Development 106:119-132.
59. +) under different mitogenic control. Neuron 5:615-625.
60. -) directly from postnatal rodent cerebrum. Neuroprotocols 2:209-218.
61. Gerber MR, Connor JR (1989): Do oligodendrocytes mediate iron regulation in the human brain? Ann Neurol 26:95-98.
62. Gilles FH, Leviton A, Kerr CS (1976): Susceptibility of the neonatal feline telencephalic white matter to a lipopolysaccharide. J Neurol Sci 27:183-191.
63. Gilles FH, Averill DR, Kerr CS (1977): Neonatal endotoxin encephalopathy. Ann Neurol 2:49-56.
64. Gocht A, Keith AB, Candy JM et al. (1993): Iron uptake in the brain of the myelin-deficient rat Neurosci Lett 154:187-190
65. Goyne GE, Wamngton AE, DeVito JA et al. (1994): Oligodendrocyte precursor quantitation and localization in perinatal brain using a retrospective bioassay. J Neurosci Res 14: 5365-5372.
66. Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R (1990): Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic Res Commun 11:181-193.
67. Halliwell B, Gutteridge J (1985): Oxygen radicals and nervous system. Trends Neurosci 7:22-26.
68. Halliwell B, Guttendge JC (1990): Role of free radicals and catalytic metal ions in human disease: An overview. In Packer AN (ed): Methods in Enzymology. vol. 186. San Diego: Academic Press, pp 1-85
69. Harris MC, Constantino AT, Sullivan JS et al. (1994). Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 124:105-111.
70. Hart IK, Richardson WD, Bolsover SR et al. (1989): PDGF and intracellular signalling in the timing of oligodendrocyte differentiation J Cell Biol 109:3411-3417.
71. Hasegawa M, Houdou S, Mito T et al. (1992): Development of myelination in the human fetal and infant cerebrum: A myelin basic protein immunohistochemical study. Brain Dev 14:1-6.
72. Hill A (1991): Current concepts of hypoxic-ischemic-cerebral injury in the term newborn. Pediatr Neurol 7:317-325.
73. Hill JM, Switzer RC (1984): The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11:595-603.
74. Houdou S, Kuruta H, Hasegawa M et al. (1991): Developmental immunohistochemistry of catalase in the human brain. Brain Res 556:267-270.
75. Husain J, Juurlink BHJ (1995): Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 698:86-94.
76. Iida K, Takashima S, Ueda K (1995): Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr Neurol 13:296-304.
77. Jacobsen M, Lassen LC, Mollgard K (1984): Immunohistochemical evidence for intracellular localization of plasma proteins in CNS and some neural crest derivatives in human embryos. Tumor Biol 5:53-60.
78. Kahn MA, De Vellis J (1994): Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12:87-98.
79. Kahn MA, Ellison JA, Speight GJ et al. (1995): CNTF regulation of astrogliosis and the activation of microglia in the developing rat central nervous system. Brain Res 685:55-67.
80. Kim YS, Kim SU (1991): Ohgodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci Res 29:100-106.
81. Kinney HC, Brody BA, Kloman AS et al. (1989): Sequence of central nervous system myelination in human infancy: II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol 47:217-234.
82. Komoly S, Hudson DL, Dewebster H, Bondy CA (1992): Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 89:1894-1898.
83. Koster JF (1986). Ferritin, a physiological iron donor for microsomal lipid peroxidation, FEBS Lett 199:85-88.
84. Lee SC, Liu W, Dickson DW et al. (1993): Cytokine production by human fetal microglia and astrocytes: Differential induction by lipopolysaccharide and IL-1β. J Neurosurg 150:2659-2667.
85. Leviton A, Gilles F (1984): Acquired perinatal leukoencephalopathy. Ann Neurol 16:1-10.
86. Leviton A, Paneth N (1990): White matter damage in preterm newborns - An epidemiologic perspective. Early Hum Dev 24:1-22.
87. Lin HH, Connor JR (1989): The development of the transferrin-transferrin receptor system in relation to astrocytes, MBP and galactorcerebroside in normal and myelin-deficient rat optic nerves. Brain Res 49:281-293.
88. Lipton SA, Rosenberg PA (1994): Mechanisms of disease: Excitatory amino acids a final common pathway for neurologic disorders. N Engl J Med 330:613-622.
89. Louis J-C, Magal E, Takayama S et al. (1993): CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689-692.
90. Macklin W, Weil CL, Deininger PL (1986): Expression of myelin proteolipid and basic protein mRNAs in cultured cells. J Neurosci Res 16:203-217.
91. Mayer M, Noble M (1994): N-aceryl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91:7496-7500.
92. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990): FGF modulates the PDGF-driven pathway of oligodendrocyte development Neuron 5:603-614.
93. McLaurin J, D'Souza S, Stewart J et al. (1995): Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 13:369-381.
94. McMorris FA, McKinnon RD (1996): Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease. Brain Pathol 6:313-329.
95. McMorris FA, Mozell RL, Carson MJ et al. (1993): Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann NY Acad Sci 692:321-324.
96. Merrill JE (1991): Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 13:130-137.
97. Merrill JE, Ignarro LJ, Sherman MP et al. (1993): Microghal cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141.
98. Mirsky R, Winter J, Abney ER, Pruss RM, Gavnlovic J, Raff MC (1980): Myelin-specific proteins and galactolipids in rat Schwann cells and oligodendrocytes in culture. J Cell Biol 84:483-494.
99. Mitrovic B, Martin FC, Charles AC et al. (1994): Neurotransmitters and cytokines in CNS pathology. Prog Brain Res 103:319-330.
100. Mitrovic B, Ignarro LJ, Vinters HV et al. (1995): Nitric oxide induces necrotic but not apoptotic death in oligodendrocytes. Neuroscience 65:531-539.
101. Mollgard K, Stagaard M, Saunders NR (1987): Cellular distribution of transferrin immunoreactivity in the developing rat brain. Neurosci Lett 78:35-40.
102. Mollgard K, Dziegieleweka KM, Saunders NR, Zakut H, Soreq H (1988): Synthesis and localization of plasma proteins in the developing human brain. Dev Biol 128:207-221.
103. Morris CM, Candy JM, Bloxham CA et al. (1992): Immunocytochemical localisation of transferrin in the human brain. Acta Anat (Basel) 143:14-18.
104. Muir DA, Compston DAS (1996): Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res 44:1-11.
105. Murphy T, Miyamoto M, Sastre A et al. (1989): Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
106. Murphy TH, Schnaar RL, Coyle JT (1990): Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4:1624-1633.
107. Nakamura Y, Okudera T, Hashimoto T (1994): Vascular architecture in white matter of neonates: Its relationship to periventricular leukomalacia. J Neuropathol Exp Neurol 53:582-589.
108. Noble M, Murray K (1984): Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J 3:2243-2247.
109. Noble M, Murray K, Stroobant P et al. (1988): Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562.
110. Noble PG, Antel JP, Yong VW (1994): Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res 633:83-90.
111. Norenberg MD (1994): Astrocyte response to CNS injury. J Neuropathol Exp Neurol 53:213-220.
112. Oka A, Belliveau MJ, Rosenberg PA et al. (1993): Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J Neurosci 13:1441-1453.
113. Ozawa H, Nishida A, Mito T et al. (1994): Development of ferritin-containing cells in the pons and cerebellum of the human brain. Brain Dev 16:92-95.
114. Paneth N, Rudelli R, Monte W et al. (1990): White matter necrosis in very low birth weight infants: Neuropathologic and ultrasonographic findings in infants surviving six days or longer. J Pediatr 116:975-984.
115. Perlman JM, Risser R, Broyles RS (1996): Bilateral cystic periventricular leukomalacia in the premature infant: Associated risk factors Pediatrics 97:822-827.
116. Pfeiffer SE, Warrington AE, Bansal R (1993): The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
117. Prabhakar S, D'Souza S, Antel JP, McLaurin J, Schipper HM, Wang E (1995): Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res 672:159-169.
118. Qi Y, Dawson G (1992): Hypoxia induces synthesis of a novel 22-kDa protein in neonatal rat oligodendrocytes. J Neurochem 59:1709-1716.
119. Qi Y, Dawson G (1994): Hypoxia specifically and reversibly induces the synthesis of ferritin in oligodendrocytes and human oligodendrogliomas. J Neurochem 63:1485-1490.
120. Qi Y, Jamindar TM, Dawson G (1995): Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J Neurochem 64:2458-2464.
121. Raff MC, Barres BA, Burne JF et al. (1993). Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695-700.
122. Raff MC, Mirsky R, Fields KL et al. (1978): Galactocerebroside is a specific cell surface antigenic marker for oligodendrocytes in culture Nature 274:813-816.
123. Raff MC, Williams BP, Miller RH (1984): The in vitro differentiation of a bipotential glial progenitor cell. EMBO J 3:1857-1864.
124. Raff MC, Lullien LE, Richardson WD, Burne JF, Noble MD (1988): Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333.562-565
125. Rangan U, Bulkley GB (1993): Prospects for treatment of free radical mediated injury. Brit Med Bull 49:700-718.
126. Ratan RR, Murphy TH, Baraban JM (1994a): Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 14:4385-4392.
127. Ratan RR, Murphy TH, Baraban JM (1994b): Oxidative stress induces apoptosis in embryonic cortical neurons, J Neurochem 62:376-79.
128. 2. J Cereb Blood Flow Metab 9:65-70.
129. Reynolds R, Wilkins GP (1988): Development of macroglial cells in rat cerebellum II: An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102:409-425.
130. Rivkin MJ, Flax J, Mozell R et al. (1995): Oligodendroglial development in human fetal cerebrum. Ann Neurol 38:92-101.
131. Robbins DS, Shirazi Y, Drysdale B-E et al. (1987): Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593-2597.
132. Rorke LB (1982): Pathology of Perinatal Brain Injury. New York: Raven Press, pp 45-63.
133. Rorke LB (1992): Perinatal brain damage. In Adams JH, Duchen LW (eds): Greenfield's Neuropathology. 5th ed. London: Edward Arnold, pp 639-709.
134. Roskams AJ, Connor JR (1992): Transfernn receptor expression in myelin deficient (md) rats. J Neurosci Res 31:421-427.
135. Sanchez I, Hassinger L, Paskevich PA, Shine HD, Nixon RA (1996): Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J Neurosci 16:5095-5105.
136. Sanderud J, Kumlin M, Granstrom E, Saugstad OD (1995): Effects of oxygen radicals on cysteinyl leukotriene metabolism and pulmonary circulation in young pigs. Eur Surg Res 27:117-126.
137. Schachner M, Kim SK, Zehnle R (1981): Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies. Dev Biol 83:328-338.
138. Scolding NJ, Morgan BP, Campbell AK et al. (1990): Complement mediated serum cytotoxicity against oligodendrocytes: A comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage. J Neurol Sci 97:155-162.
139. Scolding NJ, Morgan BP, Campbell AK, Compton DAS (1992): The role of calcium in rat oligodendrocyte injury and repair. Neurosci Lett 135:95-98.
140. Selmaj K, Raine CS, Farooq M et al. (1991): Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 147:1522-1529.
141. Shinar Y, McMoms FA (1995): Developing oligodendroglia cells express mRNA for insulin-like growth factor-1, a regulator of oligodendrocyte development. J Neurosci Res 42:516-527.
142. Sommer I, Schachner M (1981): Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.
143. Sommer I, Schachner M (1982): Cells that are 04-antigen positive and 01-negative differentiate into 01 antigen-positive oligodendrocytes. Neurosci Lett 29:183-188.
144. Taylor EM, Morgan EH (1990): Developmental changes in transferrin and iron uptake by brain in the rat Brain Res Dev Brain Res 55:35-42.
145. Thorburne SK, Juurlink BHJ (1996): Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67:1014-1022.
146. Trippodo NC, Jorgensen JH, Priano LL et al. (1973): Cerebrospinal fluid levels of endotoxin during endotoxemia Proc Soc Exp Biol Med 143:932-937.
147. Varsila E, Pitkanen O, Hallman M et al. (1994): Immaturity-dependent tree radical activity in premature infants. Pediatr Res 36:55-59.
148. Vartanian T, Li Y, Zhao M et al. (1995): Interferon-γ-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-74.
149. Volpe JJ (1995): Neurology of the Newborn. Philadelphia: WB Saunders, pp 279-369.
150. Warrington AE, Pfeiffer SE (1992): Proliferation and differentiation of 04+ oligodendrocytes in postnatal rat cerebellum: Analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res 33:338-353.
151. Wilt SG, Milward E, Zhou JM et al. (1995): In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37:381-394.
152. perina-tal progenitor cells. J Cell Biol 118:889-900.
153. Wren DR, Noble M (1989): Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci USA 86:9025-9029.
154. adult progenitor cells. J Cell Biol 116:167-176.
155. Yao DL, West NR, Bondy CA et al. (1995): Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during remyelination. J Neurosci Res 40:647-659.
156. Yasuda T, Gnnspan J, Stern J, Fransceschini B, Bannerman P, Pleasure D (1996): Apoptosis occurs in the oligodendroglial lineage and is prevented by basic fibroblast growth factor. J Neurosci Res 40:306-317.
157. Ye P, Carson J, D'Arcole AJ (1995): In vivo actions of insulin-like growth factor-1 (IGF-1) on brain myelination: Studies of IGF-1 and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15:7344-7356.
158. Yeh H-J, Ruit KG, Wang Y-X et al. (1991): PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64:209-216.
159. Yonezawa M, Back SA, Gan X et al. (1996): Cystine deprivation induces oligodendroglial death: Rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 73:566-573.
160. Yoon BH, Romero R, Yang SH et al. (1996): Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174:1433-1440.
161. Yoshioka A, Hardy M, Younkin DP et al. (1995): α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64:2442-2448.
162. Young RSK, Yagel SK, Towfighi J (1983): Systemic and neuropathologic effects of E. coli endotoxin in neonatal dogs. Pediatr Res 17:349-353.
163. Zeller NK, Behar TN, Dubois-Dalcq M et al. (1985): The timely expression of myelin basic protein gene in cultured rat brain oligodendrocytes is independent of continuous neuronal influences. J Neurosci 5:2955-2962.